By Mia MacGregor
April 7 - (The Insurer) - Ambac Financial Group has satisfied all required pre-closing conditions for the sale of its legacy financial guarantee business to funds managed by Oaktree Capital Management and has extended the deal timeline by three months pending final regulatory approval.
Oaktree is expected to receive approval to buy Ambac Assurance Corporation and Ambac UK in the second quarter of 2025, according to Ambac.
As a result, the term of the purchase agreement has been automatically extended from April 4 to July 3, 2025.
“The regulatory review process between Oaktree and the regulator continues to progress. Ambac is prepared to close the sale as soon as possible upon receipt of the final outstanding regulatory approval,” said Claude LeBlanc, president and CEO of Ambac.
Earlier this year, Ambac's share price dropped more than 20% following a fourth-quarter adjusted net loss of $1.1 million, despite LeBlanc stating that the broader excess and surplus market was “performing well”.
The quarterly result included a $570 million loss tied to the sale of the legacy financial guarantee business to Oaktree, a transaction Ambac described as “pivotal for positioning the company for long-term growth”.
The sale was approved by Ambac’s shareholders in October 2024.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。